Roger Jeffs - Net Worth and Insider Trading
Roger Jeffs Net Worth
The estimated net worth of Roger Jeffs is at least $50 Million dollars as of 2024-08-24. Roger Jeffs is the CEO of Liquidia Corp and owns about 2,407,194 shares of Liquidia Corp (LQDA) stock worth over $24 Million. Roger Jeffs is the Director of Axsome Therapeutics Inc and owns about 167,668 shares of Axsome Therapeutics Inc (AXSM) stock worth over $15 Million. Roger Jeffs is also the President & Co-CEO of United Therapeutics Corp and owns about 27,092 shares of United Therapeutics Corp (UTHR) stock worth over $9 Million. Besides these, Roger Jeffs also holds Dova Pharmaceuticals Inc (DOVA) , Sangamo Therapeutics Inc (SGMO) . Details can be seen in Roger Jeffs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Roger Jeffs has not made any transactions after 2024-07-12 and currently still holds the listed stock(s).
Transaction Summary of Roger Jeffs
Roger Jeffs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Roger Jeffs owns 7 companies in total, including Albireo Pharma Inc (ALBO) , Axsome Therapeutics Inc (AXSM) , and Dova Pharmaceuticals Inc (DOVA) among others .
Click here to see the complete history of Roger Jeffs’s form 4 insider trades.
Insider Ownership Summary of Roger Jeffs
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ALBO | Albireo Pharma Inc | 2017-09-27 | director |
AXSM | Axsome Therapeutics Inc | 2024-03-15 | director |
DOVA | Dova Pharmaceuticals Inc | 2019-11-12 | director |
![]() | ![]() | 2018-02-08 | director |
![]() | ![]() | 2018-09-07 | director |
![]() | ![]() | 2015-04-28 | director & President and COO |
![]() | ![]() | 2024-07-12 | director |
Roger Jeffs Latest Holdings Summary
Roger Jeffs currently owns a total of 5 stocks. Among these stocks, Roger Jeffs owns 2,407,194 shares of Liquidia Corp (LQDA) as of July 12, 2024, with a value of $24 Million and a weighting of 47.93%. Roger Jeffs owns 167,668 shares of Axsome Therapeutics Inc (AXSM) as of March 15, 2024, with a value of $15 Million and a weighting of 29.47%. Roger Jeffs also owns 27,092 shares of United Therapeutics Corp (UTHR) as of April 28, 2015, with a value of $9 Million and a weighting of 18.83%. The other 2 stocks Dova Pharmaceuticals Inc (DOVA) , Sangamo Therapeutics Inc (SGMO) have a combined weighting of 3.77% among all his current holdings.
Latest Holdings of Roger Jeffs
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
LQDA | Liquidia Corp | 2024-07-12 | 2,407,194 | 9.97 | 23,999,724 |
AXSM | Axsome Therapeutics Inc | 2024-03-15 | 167,668 | 87.99 | 14,753,107 |
UTHR | United Therapeutics Corp | 2015-04-28 | 27,092 | 348.03 | 9,428,829 |
DOVA | Dova Pharmaceuticals Inc | 2019-07-01 | 66,993 | 28.04 | 1,878,484 |
SGMO | Sangamo Therapeutics Inc | 2018-09-07 | 9,908 | 0.86 | 8,497 |
Holding Weightings of Roger Jeffs
Roger Jeffs Form 4 Trading Tracker
According to the SEC Form 4 filings, Roger Jeffs has made a total of 7 transactions in Liquidia Corp (LQDA) over the past 5 years, including 4 buys and 3 sells. The most-recent trade in Liquidia Corp is the sale of 8,053 shares on July 12, 2024, which brought Roger Jeffs around $100,904.
According to the SEC Form 4 filings, Roger Jeffs has made a total of 2 transactions in Axsome Therapeutics Inc (AXSM) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Axsome Therapeutics Inc is the sale of 32,323 shares on March 15, 2024, which brought Roger Jeffs around $2 Million.
According to the SEC Form 4 filings, Roger Jeffs has made a total of 0 transactions in United Therapeutics Corp (UTHR) over the past 5 years. The most-recent trade in United Therapeutics Corp is the sale of 5,000 shares on April 28, 2015, which brought Roger Jeffs around $816,550.
More details on Roger Jeffs's insider transactions can be found in the Insider Trading History of Roger Jeffs table.Insider Trading History of Roger Jeffs
- 1
Roger Jeffs Trading Performance
GuruFocus tracks the stock performance after each of Roger Jeffs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Roger Jeffs is 18.36%. GuruFocus also compares Roger Jeffs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Roger Jeffs within 3 months outperforms 3 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Roger Jeffs's insider trading performs compared to the benchmark.
Performance of Roger Jeffs
Roger Jeffs Ownership Network
Ownership Network List of Roger Jeffs
Ownership Network Relation of Roger Jeffs
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Roger Jeffs Owned Company Details
What does Albireo Pharma Inc do?
Who are the key executives at Albireo Pharma Inc?
Roger Jeffs is the director of Albireo Pharma Inc. Other key executives at Albireo Pharma Inc include director & President and CEO Cooper Ronald Harold Wilfred , Chief Human Resources Officer Michelle Graham , and CFO and Treasurer Harford Simon N.r. .
Albireo Pharma Inc (ALBO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Albireo Pharma Inc (ALBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Albireo Pharma Inc (ALBO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Albireo Pharma Inc (ALBO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Albireo Pharma Inc Insider Transactions
Roger Jeffs Mailing Address
Above is the net worth, insider trading, and ownership report for Roger Jeffs. Currently GuruFocus does not have mailing address information for Roger Jeffs.